Can I read Sunitinib in Advanced Renal Cell Carcinoma on EtoBox?

Sunitinib in Advanced Renal Cell Carcinoma by mari is a document available to read on EtoBox.

What is Sunitinib in Advanced Renal Cell Carcinoma about?

This document discusses the drug sunitinib and its role in treating advanced renal cell carcinoma over the past 10 years. Key points: - Sunitinib was approved in 2006 and established as a standard first-line therapy for advanced RCC based on clinical trial results showing significantly longer progression-free survival compared to interferon-alpha. - Further research has sought to refine the role of sunitinib through patient selection, prognostic markers, improved dosing/side effect management, and identif

Author

mari

Language

EN